TABLE 3.
Processing of FMT suspensions | |
Amount of faeces | 50 g a |
Processing | Aerobic or anaerobic |
Diluent | NaCl 0.9% |
Cryoprotectant | Glycerol 10% |
End volume | 50–60 g: 200 cc |
25–30 g: 100 cc | |
Storage | −80°C, maximum 2 years |
Timeframe between collection and storage | <6 h (rapid processing preferred) |
Treatment of patients | |
FMT preparation | Frozen stool banked preparation |
Pretreatment of patient | 4–10 Days vancomycin 125–250 mg qid (or fidaxomicin 200 mg bid) |
Stop >24 h before FMT | |
Bowel lavage with macrogol on day before FMT (Not necessary in case of capsule administration) b | |
Colonoscopy | |
Nasoduonal tube (infusion 10–25 cc/minute) | |
Capsules, if established protocol |
Abbreviations: CDI, Clostridioides difficile infection; FMT, faecal microbiota transplantation.
For upper gastrointestinal delivery for treatment of CDI, bowel lavage could be limited to 50% of the advised dose for colonoscopy cleansing.